Positron emission tomography after fetal transplantation in Huntington's disease

Annals of Neurology

Volumn 58, Issue 2, 2005, Pages 331-337

  Furtado, Sarah ^a   Sossi, Vesna ^a   Hauser, Roberta A ^b   Samii, Ali ^a   Schulzer, Michael ^a   Murphy, Colleen B ^a   Freeman, Thomas B ^c   Stoessl, A Jon ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CARBON 11; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; FLUORODEOXYGLUCOSE;

ANALYSIS OF VARIANCE; ARTICLE; BRAIN METABOLISM; BRAIN TRANSPLANTATION; CAUDATE NUCLEUS; CEREBELLUM; CHOREA; CHROMOSOME 4; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEGENERATIVE DISEASE; DEMENTIA; DRUG UPTAKE; HUMAN; HUNTINGTON CHOREA; MOTOR CORTEX; OCCIPITAL CORTEX; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PUTAMEN; RATING SCALE; RECEPTOR BINDING; STATISTICAL ANALYSIS; THALAMUS ANTERIOR NUCLEUS; THALAMUS POSTERIOR NUCLEUS; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; FETAL TISSUE TRANSPLANTATION; FOLLOW-UP STUDIES; HUMANS; HUNTINGTON DISEASE; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; RECEPTORS, DOPAMINE; TIME FACTORS;

EID: 23244461696     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20564     Document Type: Article

References (9)

1. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosome. Cell 1993;72: 971-983.
2. Hauser RA, Furtado S, Cimino CR, et al. Bilateral human fetal striatal transplantation in Huntington's disease. Neurology 2002; 58:687-695.
3. Andrews TC, Weeks RA, Turjanski N, et al. Huntington's disease progression: PET and clinical observations. Brain 1999;122: 2353-2363.
4. Antonini A, Leenders KL, Spiegel R, et al. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease. Brain 1996; 119:2085-2095.
5. Pavese N, Andrews TC, Brooks DJ, et al. Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study. Brain 2003;126:1127-1135.
6. Bachoud-Levi AC, Remy P, Nguyen J-P, et al. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet 2000;356:1975-1979.
7. Gaura V, Bachoud-Levi AC, Ribeiro MJ, et al. Striatal neural grafting improves cortical metabolism in Huntington's disease patients. Brain 2004;127:65-72.
8. Bachoud-Levi A, Hantraye P, Peschanski M, et al. Fetal neural grafts for Huntington's disease: a prospective view. Mov Disord 2002;17:439-444.
9. Freeman TB, Cicchetti F, Hauser RA, et al. Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology. Proc Natl Acad Sci U S A 2000;97:13877-13822.